NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of NGL FINECHEM ?
Year | Current Liabilities |
---|---|
Mar2023 | - |
Mar2022 | - |
Mar2021 | - |
Mar2020 | - |
Mar2019 | - |
How is Current Liabilities of NGL FINECHEM Trending?
Years | Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | - | 0 | |
Mar2022 | - | 0 | |
Mar2021 | - | 0 | |
Mar2020 | - | 0 | |
Mar2019 | - | - |
Compare Current Liabilities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,464.4 Cr | -6.8% | 10.6% | 76.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -6.8% |
10.6% |
76.3% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses